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The hot water extract of a brown marine alga, Cystoseira myrica, from the Persian Gulf was evaluated 
as an antiviral compound against KOS strain of HSV-1 in cell culture. The extract exhibited antiviral 
activity against herpes simplex virus type 1 (HSV-1) not only during absorption of virus to the cells, but 
also on post attachment stages of virus replication. The water extract of C. myrica was sterilized by 
filtration and autoclaving, respectively. The IC50 for filtered extract was 99 µg/ml and the IC50 for 
autoclaved extract was 125 µg/ml. Based on resulted selectivity index (SI) values of the extracts, which 
were 33.4 and 28.2 for filtered and autoclaved extracts, respectively, we found that the antiviral 
compound(s) in the water extract of C. myrica to be heat stable. Also, the SI values for inhibition of the 
post attachment stages of HSV-1 replication were 23.1 and 21.7 for filtered and autoclaved extracts, 
respectively. The IC50 in this phase of study were 143 and 162 µg/ml for filtered and autoclaved extracts, 
respectively. Therefore, C. myrica could be a good candidate as a natural source for anti-HSV-1 
compound(s) isolation. 
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INTRODUCTION 
 
The herpes simplex virus type 1 (HSV-1) is the primary 
cause of oral-facial and pharyngeal infections and may 
cause herpetic whitlow, as well as severe and sometimes 
dangerous infections of the eyes and brain. HSV-1 also 
accounts for 10 to 15% of all genital herpetic infections. 
This virus can produce latent infection in the host for life 
and is reactivated by stimulus to cause recurrent infec-
tions and lesions (Fields, 2001). Considering the 
complications of this virus, some synthetic antiviral 
compounds were developed for treatment of active 
herpetic infections, but they are not effective for the 
treatment of latent infections (Naesens and De Clercq, 
2001). On the other hand, the severe side effects and 
development of some resistant mutations of this virus, 
especially during long term medication with antiviral 
drugs, were reported (Malvey, 2005; Pottage and 
Kessler, 1995).  
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Therefore, for many researchers, finding new natural 
antiviral compounds is very interesting. In many studies 
looking for novel antiviral agents, some plants and algae 
extracts were tested on different viruses including the 
herpes viruses (Yoosook et al., 1999; Lopez et al., 2001; 
Lee et al., 2004; Serkedjieva, 2004). In some of these 
experiments different species of brown algae were tested 
for their antiviral activity.  
However, until now, no research has been done with 
respect to the antiviral effects of brown algae from the 
Persian Gulf and the antiviral activity of Cystoseira myrica 
has not yet been reported from any other part of the 
world. Therefore, in the present study, the anti-HSV-1 
activity of the crude water extract of this alga was 
evaluated in cell culture. 
 
 
MATERIALS AND METHODS 
 
Cell line and virus 
 
African green monkey kidney cell line (Vero) was used as a proper 
cell line for HSV-1 replication. Briefly, the cells were grown in 50  ml  
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Table 1. Inhibition of HSV-1 replication by different 
concentrations of the filtered extract (at the same time of 
virus inoculation). 
 
Extract concentration (µg/ml) CPE inhibition (%) 
20 0 
40 10 
60 25 
80 40 
10 50 
130 75 
130 75 
150 85 
170 100 
 
 
 
Table 2. Inhibition of HSV-1 replication by different 
concentrations of the autoclaved extract (at the same time of 
virus inoculation). 
 
Extract concentration (µg/ml) CPE inhibition (%) 
20 0 
50 5 
80 15 
100 30 
120 45 
130 55 
170 80 
200 100 
 
 
 
cell culture flasks (NUNC) or 24 well cell culture microplates 
(NUNC) by using Dulbeccos Minimum Essential Medium (Gibco) 
containing 10% foetal bovine serum (Gibco). Herpes simplex virus 
type 1, KOS strain, was received as a gift from the virology 
department of Tarbiat Modarres University. The virus was propaga-
ted in Vero cells and the titre of propagated viral stock was 
determined as TCID50/ml by using Karber method. 
 
 
Cytotoxicity test 
 
The cytotoxicity of alga extract was determined by culturing Vero 
cells for five days in the presence of increasing amounts of extract. 
Viable cells were determined by the trypan blue exclusion test. The 
results were plotted, at dose response curve and by using STATA 
statistical software, the 50% cell growth inhibitory concentration 
(CC50) was obtained. 
 
 
Antiviral activity assay (CPE Inhibition assay) 
 
Vero cells were grown in 24-well plastic plates (7 × 103 cells /well). 
Then the plates were incubated at 37ºC in the presence of 5% CO2 
until the cells became confluent. Thereafter, the culture medium 
was removed from each well 0.1 ml of virus suspension containing 
10000 TCID50 and 0.1 ml of DMEM containing 2% FBS were mixed 
in each well of the 24-well plates and appropriate concentrations of 
the extract from minimal to maximal non-cytotoxic concentration 
were added to each well based on serial dilution preparation. For 
the virus control, 0.1 ml of virus suspension  and  0.1  ml  of  culture  
 
 
 
 
medium without extract were used. For the cell control, 0.1 ml of 
culture medium with maximal non cytotoxic concentration of extract 
was added. 
The plates were incubated at 37ºC in a humidified CO2 
atmosphere (5% CO2) and were investigated every day for CPE 
presentation until day 5 post infection. For testing the probable post 
attachment antiviral effect of the extract, the same protocol men-
tioned above was performed, but the addition of the extract was two 
hours post inoculation of cells with virus. The degree of inhibition 
was expressed as percent yield of virus control (% virus control = 
CPE experimental group/ CPE virus control ×100). The concen-
tration of extract which reduced CPE 50% with respect to virus 
control was estimated from graphic plots defined as 50% inhibitory 
concentration (IC50) expressed in microgram per milliliter by using 
STATA modeling software. The selectivity index (SI) was measured 
from the ratio of CC50/IC50 (Kudi and Myrint, 1999; Kujumgier et al., 
1999). 
 
 
Preparation of alga extract 
 
C. myrica was collected along the Bushehr coast of the Persian 
Gulf (Southwest of Iran). About 100 g of the fresh alga, corres-
ponding to 10 – 12 g of dry alga material was homogenized in 500 
ml cold double distilled water. The mixture was clarified by filtration 
using Whatman No.1 filter paper and the light brown extract 
resulted. The water extract of C. myrica were sterilized by filtration 
and autoclaving, respectively. These extracts were tested for their 
antiviral and cytotoxic activity. 
 
 
Statistical analysis 
 
STATA statistical analysis package was used for drawing the dose 
response curve in order to IC50 and CC50 calculation.  
 
 
RESULTS 
 
The cytotoxicity of C. myrica extracts which were 
sterilized by filtration and autoclaving methods on Vero 
cells were determined by calculation of CC50. The resulted 
CC50 for filtered and autoclaved extracts were 3310 and 
3528 µg/ml respectively. Treatment of the Vero cells with 
different concentrations of the cold water extract at the 
same time of inoculation by HSV-1 was done. Based on 
data shown in Table 1, 20 µg/ml of the filtered extract did 
not show any antiviral effect, while the application of 170 
µg/ml of that extract lead to 100% inhibition of CPE 
formation due to HSV-1 replication in Vero cells. There-
fore, the IC50 of this extract by using STATA software is 
99 µg/ml. The data for autoclaved crude extract of C. 
myrica is shown in Table 2. We found that 20 µg/ml of the 
autoclaved extract didn’t show any anti-HSV-1 effect; 
although 200 µg/ml of that extract lead to 100% inhibition 
of HSV -1 related CPE formation. The IC50 for the 
autoclaved extract in this part of the study was calculated 
to be 125 µg/ml. The SI values were calculated at 33.4 
and 28.2 for filtered and autoclaved extracts, respective-
ly, based on the IC50 and CC50 from each extract. 
Also, antiviral activity of the crude extracts was eva-
luated on post attachment stages of the virus replication 
cycle. In this phase of research, based on the data in 
Table 3, we have found that 20 µg/ml  of  the  filtered  ex-  
  
 
 
Table 3. Inhibition of HSV-1 replication by different 
concentrations of the filtered extract (after virus attachment to 
the cell). 
 
Extract concentration (µg/ml) CPE inhibition (%) 
20 0 
40 5 
60 10 
110 25 
130 40 
150 50 
170 70 
210 100 
 
 
 
tract could not prevent the performing of cytopathic effect 
of HSV-1 in Vero cells but 210 µg/ml of that extract 
inhibited the HSV-1 related CPE formation 100% in cell 
culture. The IC50 value for filtered extract is 143 µg/ml. 
The data in Table 4 shows the CPE inhibition of the 
different concentration of autoclaved extract on post 
attachment stages of HSV-1 replication cycle. As shown 
in Table 4, 240 µg/ml of autoclaved extract could prevent 
the CPE exhibition of HSV-1 in cell culture 100%, 
whereas a concentration of 20 µg/ml of that extract didn’t 
show any anti-HSV-1 effect. Therefore, the IC50 of that 
extract in this phase of study was 162 µg/ml. The SI 
values for filtered and autoclaved extracts in this part of 
the research were 23.1 and 21.7, respectively. 
 
 
DISCUSSION 
 
Interest in employing antiviral compounds from natural 
sources like plants or algae has been enhanced by 
researchers and the consumers’ preference for natural 
medicines and concerns about the toxic effects of 
synthetic antiviral materials. There are some publications 
about antiviral properties of different species of marine 
algae such as brown, green and red algae (Damonte et 
al., 1996; Lopez et al., 2001; Lee et al., 2004; 
Serkedjieva, 2004; Richards et al., 1978; Preeprame et 
al., 2001; Ghosh et al., 2004; Hayashi et al., 2006; Pujol 
et al., 2006). In most studies done in this area, the 
viruses tested belonged to the herpesviridae family, 
especially herpes simplex viruses. In the present study 
we chose HSV-1 for our research because of its ability to 
perform different clinical complications and its increasing 
prevalence in communities (Rosen, 2006). Also, HSV-1 is 
a good example of enveloped viruses. Therefore, the 
discovery of natural antiviral compounds should be 
interesting. In some studies in this direction, some brown 
algae were tested. However, until now there has been no 
other study on the antiviral effect of C. myrica. This was 
valuable for us especially because we had easy access 
to this alga on the Bushehr coast. 
We have prepared water extract and for the sterilization 
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Table 4. Inhibition of HSV-1 replication by using different 
concentrations of the autoclaved extract (after virus attachment 
to the cell). 
 
Extract concentration (µg/ml) CPE inhibition (%) 
20 0 
60 5 
100 20 
130 35 
160 45 
170 50 
220 80 
240 100 
 
 
 
of the extract we have used a filtration method besides 
autoclaving. We have found that the autoclaved extract 
showed the acceptable IC50 and based on SI values of 
this extract, it could be a good choice for anti- HSV-1 
natural compound, although in most studies the filtering 
method was used for extract sterilization. The IC50 values 
for filtered and autoclaved extracts tested at the same 
time as that of virus inoculation were 99 and 125 µg/ml, 
respectively. Also, the SI values were 33.4 and 28.2 for 
the filtered and autoclaved extracts. This data showed 
that the crude extract of C. myrica could prevent the initial 
stages of HSV-1 replication such as absorption, attach-
ment and/or entry to the host cell. 
In another step of our research, we tested the 
autoclaved and filtered extract for their probable post 
attachment inhibition effects on HSV-1 replication. Based 
on IC50 value of each extract, the SI for filtered extract 
was 23.1 and for the autoclaved extract was 21.7. There-
fore, the water extracts of C. myrica also exhibit antiviral 
effect on post attachment stages of HSV-1 to the Vero 
cells, probably on internalization of virus to the cells 
because we have done this phase of study at 37ºC. 
Meanwhile, in one study which evaluated the antiviral 
activity of sulphated polysaccharides from Sargassum 
patens, a brown alga, against HSV-2, suggested that the 
antiviral mode of action of purified sulphated polysac-
charide of that alga could be ascribed to the inhibition of 
virus adsorption (Zhu et al., 2004). Also, in another study 
the antiviral effect of diterpens from Dictyota pfaffi a 
Brazilian brown alga, on HSV-1 was evaluated and the 
results indicated that the diterpenes affected an early 
step of the replicative cycle (Barbosa et al., 2004). These 
results suggested that C. myrica water extract might be a 
candidate for natural antiherpetic compound develop-
ment. Further investigations such as purification of water 
crude extract and in vivo studies are recommended for 
future studies. 
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